These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetics of pipecurium bromide in the rat. Bodrogi L; Fehér T; Váradi A; Vereczkey L Arzneimittelforschung; 1980; 30(2a):366-70. PubMed ID: 6248081 [No Abstract] [Full Text] [Related]
5. Disposition of pipecurium bromide in rats. Vereczkey L; Szporny L Arzneimittelforschung; 1980; 30(2a):364-6. PubMed ID: 6248080 [TBL] [Abstract][Full Text] [Related]
6. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)]. Tuba Z; Mahó S Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans. Tassonyi E; Szabó G; Vereczkey L Arzneimittelforschung; 1981; 31(10):1754-6. PubMed ID: 6274362 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide. Wierda JM; Szenohradszky J; De Wit AP; Zentai G; Agoston S; Kakas M; Kleef UW; Meijer DK Eur J Anaesthesiol; 1991 Nov; 8(6):451-7. PubMed ID: 1662599 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and disposition of pipecuronium bromide in dogs with and without ligated renal pedicles. Khuenl-Brady KS; Sharma M; Chung K; Miller RD; Agoston S; Caldwell JE Anesthesiology; 1989 Dec; 71(6):919-22. PubMed ID: 2556065 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopharmacology of Arduan]. Mészáros C Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic effects of pipecuronium bromide (Arduan)]. Kárpáti E; Bíró K Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913 [TBL] [Abstract][Full Text] [Related]
12. Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action. Caldwell JE; Castagnoli KP; Canfell PC; Fahey MR; Lynam DP; Fisher DM; Miller RD Br J Anaesth; 1988 Dec; 61(6):693-7. PubMed ID: 2849968 [TBL] [Abstract][Full Text] [Related]
13. [Pharmaceutic development of injectable Arduan]. Deákné RE; Guti Z; Rádi E Acta Pharm Hung; 1992 May; 62(3):115-20. PubMed ID: 1323912 [TBL] [Abstract][Full Text] [Related]
14. The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide. Caldwell JE; Canfell PC; Castagnoli KP; Lynam DP; Fahey MR; Fisher DM; Miller RD Anesthesiology; 1989 Jan; 70(1):7-12. PubMed ID: 2536254 [TBL] [Abstract][Full Text] [Related]
15. Clinical experiences with pipecuronium bromide. Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488 [TBL] [Abstract][Full Text] [Related]
17. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children]. Praefort L Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)]. Laukó A; Horváth P; Trischler F; Görög S Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917 [TBL] [Abstract][Full Text] [Related]